These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 16769295)

  • 61. [Lamotrigine in the treatment of bipolar disorder, a review].
    van der Loos ML; Kölling P; Knoppert-van der Klein EA; Nolen WA
    Tijdschr Psychiatr; 2007; 49(2):95-103. PubMed ID: 17290338
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lamotrigine: a review of clinical studies in bipolar disorders.
    Zerjav-Lacombe S; Tabarsi E
    Can J Psychiatry; 2001 May; 46(4):328-33. PubMed ID: 11387788
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Risk of postpartum episodes in women with bipolar disorder after lamotrigine or lithium use during pregnancy: A population-based cohort study.
    Wesseloo R; Liu X; Clark CT; Kushner SA; Munk-Olsen T; Bergink V
    J Affect Disord; 2017 Aug; 218():394-397. PubMed ID: 28501739
    [TBL] [Abstract][Full Text] [Related]  

  • 64. New data on the use of lithium, divalproate, and lamotrigine in rapid cycling bipolar disorder.
    Calabrese JR; Rapport DJ; Youngstrom EA; Jackson K; Bilali S; Findling RL
    Eur Psychiatry; 2005 Mar; 20(2):92-5. PubMed ID: 15797691
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder.
    Bowden CL; Calabrese JR; Ketter TA; Sachs GS; White RL; Thompson TR
    Am J Psychiatry; 2006 Jul; 163(7):1199-201. PubMed ID: 16816224
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical outcome of valproate maintenance treatment in bipolar I disorder at Srinagarind Hospital.
    Paholpak S; Jaikasemwong S; Roumcharoenkiat A; Paholpak P; Rangseekajee P
    J Med Assoc Thai; 2014 Apr; 97(4):431-8. PubMed ID: 24964686
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The effect of lamotrigine on platelet monoamine oxidase type B activity in patients with bipolar depression.
    Muck-Seler D; Sagud M; Mustapic M; Nedic G; Babic A; Mihaljevic Peles A; Jakovljevic M; Pivac N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1195-8. PubMed ID: 18423830
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine.
    Passmore MJ; Garnham J; Duffy A; MacDougall M; Munro A; Slaney C; Teehan A; Alda M
    Bipolar Disord; 2003 Apr; 5(2):110-4. PubMed ID: 12680900
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine.
    van der Loos ML; Mulder P; Hartong EG; Blom MB; Vergouwen AC; van Noorden MS; Timmermans MA; Vieta E; Nolen WA;
    Acta Psychiatr Scand; 2010 Sep; 122(3):246-54. PubMed ID: 20136801
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lamotrigine in the treatment of bipolar depression.
    Bowden CL; Mitchell P; Suppes T
    Eur Neuropsychopharmacol; 1999 Aug; 9 Suppl 4():S113-7. PubMed ID: 10524837
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Separate and concomitant use of lamotrigine, lithium, and divalproex in bipolar disorders.
    Lieberman DZ; Goodwin FK
    Curr Psychiatry Rep; 2004 Dec; 6(6):459-65. PubMed ID: 15538995
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [The treatment of mood stabilizers in children and adolescents suffering from bipolar affective disorder].
    Green T; Shoval G; Weizman A
    Harefuah; 2005 Nov; 144(11):810-5, 821. PubMed ID: 16358659
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature.
    Ketter TA; Calabrese JR
    J Clin Psychiatry; 2002 Feb; 63(2):146-51. PubMed ID: 11874216
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The current understanding of lamotrigine as a mood stabilizer.
    Hahn CG; Gyulai L; Baldassano CF; Lenox RH
    J Clin Psychiatry; 2004 Jun; 65(6):791-804. PubMed ID: 15291656
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lamotrigine: when and where does it act in affective disorders? A systematic review.
    Amann B; Born C; Crespo JM; Pomarol-Clotet E; McKenna P
    J Psychopharmacol; 2011 Oct; 25(10):1289-94. PubMed ID: 20823080
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder.
    Goldberg JF; Bowden CL; Calabrese JR; Ketter TA; Dann RS; Frye MA; Suppes T; Post RM
    Biol Psychiatry; 2008 Jan; 63(1):125-30. PubMed ID: 17543894
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review.
    van den Ameele S; van Diermen L; Staels W; Coppens V; Dumont G; Sabbe B; Morrens M
    J Affect Disord; 2016 Oct; 203():364-373. PubMed ID: 27344047
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of lamotrigine in the maintenance treatment of Chinese adult patients with bipolar I disorder.
    Zhang L; Zhang H; Lv LX; Tan Q; Xu X; Hu J; Zi L; Cooper J; Phansalkar A; Wang G
    Int J Bipolar Disord; 2022 Aug; 10(1):20. PubMed ID: 35909213
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Lamotrigine in bipolar disorder: preventing depression to treat the disease].
    Cuomo A; Amore M; Vampini C; Fagiolini A
    Riv Psichiatr; 2021; 56(1):1-11. PubMed ID: 33560270
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bipolar disorder therapeutics: maintenance treatment.
    Sachs GS; Thase ME
    Biol Psychiatry; 2000 Sep; 48(6):573-81. PubMed ID: 11018228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.